Aimmune Therapeutics
Aimmune Therapeutics is a food allergy therapies founded in 2011 by Bryan Walser.
2
Funding Rounds
$97.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Br*** Wa**** | - | - |
Funding
Funding series
Funding Series Analysis
The company Aimmune Therapeutics has raised a total of $97m in funding over 2 rounds.
Key Insights:
- Aimmune Therapeutics Series B Mar 12, 2015: $80m
- Aimmune Therapeutics Series A round: $17m
Aimmune Therapeutics Series B Mar 12, 2015
$80m
Aimmune Therapeutics Series A round
$17m
Industries
Aimmune Therapeutics is active in the following industries:
- Technology
- Engineering
- Biomedical engineering
- Biology
- Biotechnology
- Healthcare
- Therapeutics